Retinal Surgery Devices Market By Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Retinal Laser Equipment, Retinal Tamponades and Sclera Buckles, Surgical Instruments), By Application (Diabetic Retinopathy, Epiretinal Membrane, Retinal Detachment, Macular Hole, Eye Injuries, Eye Infections), By Usage Area (Hospitals, Ophthalmology Clinics, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Growing technological progress and an increasing number of surgical instrument applications are two major factors driving the growth of this market. Growing instances of ophthalmic and retinal disorders in the geriatric population, eye injuries, and the increasing prevalence of diabetes are also accelerating the growth of the global retinal surgery devices market. In contrast, the high cost of surgical equipment is preventing the widespread adoption of advanced surgical devices. However, as the number of new surgical establishments expands in emerging economies, the adoption of new devices will be critical in sustaining global market growth. Another prominent factor supporting this market is the collection of major advantages such as minimally invasive procedures, lesser pain, reduced scarring, and a quick recovery period with lower procedure and management costs.

Market Synopsis

Vitrectomy packs will dominate the market.

In terms of device types, this market is categorized into vitrectomy machines, vitrectomy packs, microscopic illumination equipment, retinal laser equipment, retinal tamponades and sclera buckles, and surgical instruments. Of these device types, vitrectomy packs hold the largest revenue in the global market and are anticipated to retain their dominance through the forecast period. The indispensable nature of these products during retinal surgeries, easy accessibility, and usage prowess across several procedures are the prime aspects of this segment. Other characteristic benefits acquired from using vitrectomy packs are reduced procedure time and the maintenance of sterile conditions with the use of single-use instruments included in the packs.

High demand is anticipated for devices for treating retinal detachment.

Currently, retinal surgery devices are mainly consumed in the treatment of diabetic retinopathy. The high prevalence of diabetes worldwide and the growing incidence of related complications such as diabetic retinopathy are driving more and more patients to seek surgical treatments for diabetic retinopathy. This segment shall witness an upswing in terms of market penetration in emerging markets such as China and India, as the patient pool for diabetic retinopathy is consistently growing in this region. On the other hand, Retinal detachment is expected to be the fastest-growing segment during the forecast period. Prominent factors supporting the growth of the retinal detachment surgical devices market are the growing senescent population and the emergence of severe conditions leading to the formation of scar tissue, retinal tears, and so on. Moreover, growing clinical evidence establishing the benefits of surgeries for the treatment of retinal detachment is also supporting the growth of this market.

Hospitals spearhead the overall market for retinal surgery devices.

Hospitals are the largest revenue-generating segment in the global retinal surgery devices market. Greater patient footfall is among the most important factors attributed to the commanding hold of this segment. This leads hospitals to have greater affordability for advanced surgical solutions, better operational efficiencies, improved treatment outcomes for patients, and so on. Furthermore, the variety of patients coming to hospitals also makes it vital for hospitals to use retinal surgery devices. Decentralization of hospital operations and increasing initiatives by governments have led to a growing footprint of ophthalmology clinics worldwide. This is done not only to keep procedure costs down but also to make it easier for patients who live in remote areas. 

larger incidence of ophthalmic conditions to support the dominance of the North American market

In the base year 2017, North America was observed to be the largest regional market for retinal surgery devices. Growing prevalence of ophthalmologic diseases in the geriatric population and high prevalence of diabetic retinopathy In the U.S. alone, about one in three diabetic patients has diabetic retinopathy. Technological evolution in the field of minimally invasive and microscopic surgeries and corresponding growth in awareness is leading more and more patients to opt for surgical measures to treat retinal diseases. Additionally, Asia Pacific is expected to record the highest market growth during the forecast period. Large populations, consistently increasing prevalence of diabetes, improving healthcare infrastructure, and healthcare expenditure is the key drivers of the Asia Pacific market.

Periods of History and Forecast

2016: Historic year.

2017: Base Year

2018-2026: Forecast Period

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The retinal surgery devices market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on type, application, usage area, and geography.

By Type (2016-2026; millions of dollars)

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Microscopic Illumination Equipment
  • Retinal Laser Equipment
  • Retinal Tamponades and Sclera Buckles
  • Surgical Instruments

By According to Application (2016-2026; US$ Mn)

  • Diabetic Retinopathy
  • Epiretinal Membrane
  • Retinal Detachment
  • Macular Hole
  • Eye Injuries
  • Eye Infections

By application area (2016-2026; US$ Mn),

  • Hospitals
  • Ophthalmology Clinics
  • Others

By Geography Segment (2016-2026; millions of dollars)

North America

  • U.S.
  • Canada


  • U.K.
  • Germany
  • Rest of Europe

Asia-Pacific (APAC)

  • China
  • Japan
  • Rest of APAC

Latin America (LATAM)

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa (MEA)

  • GCC
  • Rest of the Middle East and Africa

This report also includes a company profiles section that gives insights into the company overview, product portfolio, financial information, and key developments of major market players. The major players profiled in this report include Alcon (Novartis AG), Bausch & Lomb Incorporated, Carl Zeiss AG, Ellex Medical Lasers, Escalon Medical Corp., ERBE Elektromedizin GmbH, IRIDEX Corporation, Topcon Corporation, Second Sight Medical Products, Inc., and Leica Microsystems GmbH.

Key questions are answered in this report.

  • What is the current and projected market size of the global retinal surgery devices market during the period 2016 to 2026?
  • What is the market position of the vitrectomy packs segment in the global industry?
  • Which segments, in terms of applications, hold prominence in the global retinal surgery devices market?
  • What are the key opportunity zones in Asia Pacific's key regional market?
  • What are the key market entry strategies employed by emerging players?

Frequently Asked Questions:

The market for Retinal Surgery Devices Market is expected to reach US$ 3,548.2 Mn by 2026.

The Retinal Surgery Devices Market is expected to see significant CAGR growth over the coming years, at 7.6%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Bausch & Lomb Incorporated, Carl Zeiss AG, Ellex Medical Lasers, Escalon Medical Corp., ERBE Elektromedizin GmbH, IRIDEX Corporation, Topcon Corporation, Second Sight Medical Products, Inc., and Leica Microsystems GmbH are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Feb 2019
Category:  Medical Devices
Report ID:   58666
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support